Article
Nuclear AREG affects a low-proliferative phenotype and contributes to drug resistance of melanoma.
International journal of cancer - 15 Dec 2022
Seefried Felix, Haller Lucia, Fukuda Shinji, Thongmao Aranya, Schneider Nadja, Utikal Jochen, Higashiyama Shigeki, Bosserhoff Anja Katrin, Kuphal Silke
Abstract excerpt
AMPHIREGULIN (AREG) is a multifaceted molecule, which acts not only as an extracellular ligand for EGF receptor (EGFR), but also as an intracellular signaling molecule. It remains elusive, however, whether AREG has a tumor suppressive or oncogenic role in melanoma. Here, we found that several melanoma cell lines express AREG, but the expression does not correlate with that of EGFR. Recombinant AREG and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
